- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04489563
Feasibility Study of i-ACT in Aged Persons (i-ACT-aged)
Intelligent Activity-based Client-centred Training (i-ACT) in Aged Persons
A mix-method cross-sectional feasibility study performed in five aged care institutes in Flanders, Belgium. A convenience sample of 48 aged persons was recruited and 12 supervisors (i.e. occupational therapy students and therapists).
Aged persons received a 20-30 minutes test with a technology-based system, i.e. intelligent Activity-based Client-centred Training system (i-ACT). The i-ACT consists of the Microsoft Kinect and adapted software in which movements can be recorded and training parameters can be set by supervisors.
During and after the test, the thinking aloud method was used. After the test, the Intrinsic Motivation Inventory, the System Usability Scale, and the Credibility/Expectancy Questionnaire were administered in the aged persons.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Limburg
-
Hasselt, Limburg, Belgium, 3500
- Plankeweeke
-
Riemst, Limburg, Belgium, 3770
- Begralim
-
Tongeren, Limburg, Belgium, 3717
- Begralim
-
Zonhoven, Limburg, Belgium, 3520
- DVC H. Catharina
-
Zonhoven, Limburg, Belgium, 3520
- WZC H. Catharina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- a client of the participating centres
- cognitively able to understand and respond to questions
- follow up instructions
- understand and speak the Dutch language
Exclusion Criteria:
- severe spasticity that unables participants to perform exercises
- severe visual impairment (e.g. blindness, cataract, etc.)
- severe communication disorder that unables participants to understand and follow up instructions (e.g. aphasia, agnosia, etc.)
- persons who use electric wheelchairs who are not able to make a transfer towards a chair.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Aged persons
A feasibility test of 20-30 minutes in aged persons with an adapted Kinect-based system, i.e. i-ACT.
|
Performing exercises with an adapted motion detection device (i.ACT) for 20-30 minutes.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intrinsic motivation
Time Frame: 30 minutes
|
Using the Intrinsic Motivation Inventory to record motivational aspects
|
30 minutes
|
|
Usability of i-ACT
Time Frame: 10 minutes
|
Using the System Usability Scale to explore the usability of i-ACT in aged persons.
The System Usability Scale consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree.
The items scores are converted into a score from 0 (negative) to 100 (positive).
A score of 72.5 or higher is considered good and above 85.0 is excellent.
|
10 minutes
|
|
Credibility/expectancy
Time Frame: 10 minutes
|
Using the Credibility/Expectancy Questionnaire to research the credibility and expectancy of aged persons when using the i-ACT for physical activity.
It is one test that consists of 2 subscales, i.e. credibility and expectancy, and scores range from 1 (totally not) to 9 (totally yes) and percentages.
The percentages are converted to scores on a scale of 1 to 9/ The maximum score on each subscale is 27.
A score of 13.5 is considered neutral, everything above 13.5 is positive while everything under 13.5 is considered negative.
|
10 minutes
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- i-ACT elderly
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Feasibility of a Technology-based System in Aged Person
-
University Hospital, BordeauxUniversity of BordeauxCompletedEvaluation of a National Health Information Technology-based Program to Improve Healthcare Coordination and Access to InformationFrance
-
GE HealthcareCompletedGather Feasibility Data and User Feedback on Use of a Device in Vivo on Pregnant Volunteers in Their 2nd and 3rd TrimesterUnited States
-
Beijing Children's HospitalCompletedA Study on the Effect of Animation-based Nurse-Patient Interaction Model on Postoperative Pain in Children With Congenital Heart DiseaseChina
-
Hamad Medical CorporationUnknownit is a Group of Metabolic Diseases in | Which a Person Has High Blood Sugar, Either | Because the Body Does Not Produce Enough Insulin, | or Because Cells do Not Respond to the Insulin That | is Produced.
-
Children's Mercy Hospital Kansas CityCompletedExtracorporeal Membrane Oxygenation Complication | Acute Brain Injury | Feasibility and Safety of a Low-field MRIUnited States
-
University of California, San FranciscoUniversity of California, DavisNot yet recruitingParticipants Must be Women Aged 25 Years or Older | Participants Should Have no Self-reported History of Heart Disease or Stroke | Participants Should Have no Terminal Illness or Diagnosed Cognitive Impairment, Including Alzheimer's Disease | Participants Should Not be a Healthcare Professionals... and other conditionsUnited States
-
Hillel Yaffe Medical CenterBen-Gurion University of the NegevNot yet recruitingEnhancing Early Language and Cognitive Development in Toddlers Through a Culturally Adapted Home-based Parent InterventionIsrael
-
Sheba Medical CenterUnknownTo Demonstrate That the Closed Loop System Can be Used Safely Over a Few Consecutive Days. | To Assess Effectiveness in Maintaining Patients' Glucose Levels in the Target Range of 70 to 180 mg/dl, Measured by Blood Glucose Sensor. | To Evaluate the User Experience With a Closed Loop...Israel
-
China Medical University HospitalUnknownA Study of Clinical and Genetic Mutations in a Family of Neuromyotonia, so Called Isaac's SyndromeTaiwan
-
Lusofona UniversityUniversity of Oslo; COFAC Cooperativa de Formacao e Animacao Cultural CRL (Portugal) and other collaboratorsNot yet recruitingCardiovascular Diseases | Diabetes | Medication Adherence | Polypharmacy | Dose Administration Aids | Technology in HealthPortugal
Clinical Trials on i-ACT
-
Karolinska InstitutetRegion Stockholm; Forte; Stiftelsen Frimurarna BarnhusetActive, not recruitingDepression | Stress, Psychological | Intellectual Disability | Anxiety | Neurodevelopmental Disorders | Traumatic Brain Injury | Autism Spectrum Disorder | Parents | Attention Deficit Hyperactivity Disorder | Physical DisabilitySweden
-
Karolinska InstitutetCompletedMental Health | Performance Anxiety | Performance EnhancementSweden
-
PXL University CollegeSt-Trudo hospital, St-Truiden, BelgiumNot yet recruitingArthroplasty | Neurologic Disorder
-
PXL University CollegeHasselt University; Ziekenhuis Oost-Limburg; Revalidatie & MS Centrum OverpeltCompletedCentral Nervous System Diseases | AgedBelgium
-
Chinese University of Hong KongRecruiting
-
Seattle Children's HospitalPatient-Centered Outcomes Research InstituteCompleted
-
University of AmsterdamCompleted
-
Idorsia Pharmaceuticals Ltd.CompletedSafety, Tolerability, Pharmacokinetics and PharmacodynamicsFrance
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
PXL University CollegeUniversitaire Ziekenhuizen KU Leuven; Hasselt University; Jessa Hospital; Ziekenhuis... and other collaboratorsCompletedCentral Nervous System Diseases | Neurological Rehabilitation